The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
Open accessAbstract
Ever since the first case was reported at the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) has become a serious threat to public health globally in short time. At this point in time, there is no proven effective therapy. The interactions with concomitant disease are largely unknown, and that may be particularly pertinent to inherited arrhythmia syndrome. An arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome. This may be of importance for patients with an increased risk of cardiac arrhythmias, either secondary to acquired conditions or comorbidities or consequent to inherited syndromes. Management of patients with inherited arrhythmia syndromes such as long QT syndrome, Brugada syndrome, short QT syndrome, and catecholaminergic polymorphic ventricular tachycardia in the setting of the COVID-19 pandemic may prove particularly challenging. Depending on the inherited defect involved, these patients may be susceptible to proarrhythmic effects of COVID-19–related issues such as fever, stress, electrolyte disturbances, and use of antiviral drugs. Here, we describe the potential COVID-19–associated risks and therapeutic considerations for patients with distinct inherited arrhythmia syndromes and provide recommendations, pending local possibilities, for their monitoring and management during this pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2
Escayg, A., MacDonald, B. T., Meisler, M. H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., et al. (2000) · Nature Genetics · doi:10.1038/74159 · Cited by 996
Cited by
Siripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., Cooper, L. T., & Chahal, C. A. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.001 · Cited by 789
Myocardial injury and COVID-19: Possible mechanisms
Babapoor-Farrokhran, S., Gill, D., Walker, J., Rasekhi, R. T., Bozorgnia, B., & Amanullah, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117723 · Cited by 481
Covid-19 and the cardiovascular system: a comprehensive review
Azevedo, R. B., Botelho, B. G., Hollanda, J. V. G. D., Ferreira, L. V. L., Junqueira de Andrade, L. Z., Oei, S. S. M. L., Mello, T. D. S., & Muxfeldt, E. S. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-0387-4 · Cited by 364
Chorin, E., Wadhwani, L., Magnani, S., Dai, M., Shulman, E., Nadeau-Routhier, C., Knotts, R., Bar-Cohen, R., Kogan, E., Barbhaiya, C., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.014 · Cited by 295
Tajbakhsh, A., Gheibi Hayat, S. M., Taghizadeh, H., Akbari, A., inabadi, M., Savardashtaki, A., Johnston, T. P., & Sahebkar, A. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822737 · Cited by 272
Metadata
- Authors
- Wu, C.-I., Postema, P. G., Arbelo, E., Behr, E. R., Bezzina, C. R., Napolitano, C., Robyns, T., Probst, V., Schulze-Bahr, E., Remme, C. A., & Wilde, A. A. M.
- Venue
- Heart Rhythm
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 17
- Issue
- 9
- Pages
- 1456-1462
- ISSN
- 1547-5271 (ISSN-L)
- OpenAlex
- W3014374025
- Cited by
- 216
- References
- 3
- FWCI
- 27.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. https://app.cochat.ai/papers/10.1016/j.hrthm.2020.03.024
- The paper
- Wu, C.-I., Postema, P. G., Arbelo, E., Behr, E. R., Bezzina, C. R., Napolitano, C., Robyns, T., Probst, V., Schulze-Bahr, E., Remme, C. A., & Wilde, A. A. M. (2020). SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2020.03.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.